Chiral separation of sitagliptin phosphate enantiomer by HPLC using amylose based chiral stationary phase

Sahajwalla, 2004, vol. 141, 421 Beesley, 1998, 23 ICH Topic Q6A Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q6A /Step4/Q6Astep4.pdf Accessed 01.12. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline, decision tree #5. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q6A/Step4/Decision_Trees.pdf Accessed 01.12. Deepthi, 2013, Stability-indicating RP-HPLC method for analysis of sitagliptin in the bulk drug and it’s pharmaceutical dosage form, Int J Pharm Pharm Sci, 5, 320 Jeyabalan, 2013, Analytical method development and validation of sitagliptin phosphate monohydrate in pure and tablet dosage form by derivative spectroscopy, J Appl Pharm Sci, 3, 95 Sharma, 2012, Development of UV-spectrophotometry and RP-HPLC method and its validation for simultaneous estimation of sitagliptin phosphate and simvastatin in marketed formulation, Int J Pharm Biol Arch, 3, 673 Kavitha, 2012, Development and validation of stability indicating RP-HPLC method for the simultaneous estimation of sitagliptin and simvastatin, Int Res J Pharm, 3, 123 Loni, 2012, Method development and validation for simultaneous determination of sitagliptin phosphate and metformin hydrochloride by RP-HPLC in bulk and tablet dosage form, Asian J Pharm Sci Res, 2, 23 Shyamala, 2011, Validated RP-HPLC for simultaneous estimation of sitagliptin phosphate and metformin hydrochloride in tablet dosage form, Am J Pharmtech Res, 1, 93